FDA’s “Dysfunctional” Hiring System May Be Good For Safety Databases
Executive Summary
FDA's difficulty in hiring additional personnel has produced one upside for the agency: extra money that can be put into other operations
You may also be interested in...
CDER, ORA To Be Major Beneficiaries Of Speedier FDA Hiring Process
As Congress debates increased funding and other steps to improve FDA oversight of imported drugs, the agency plans to hire 1,317 people in the next six months to bring staff numbers up to their full authorized levels
CDER, ORA To Be Major Beneficiaries Of Speedier FDA Hiring Process
As Congress debates increased funding and other steps to improve FDA oversight of imported drugs, the agency plans to hire 1,317 people in the next six months to bring staff numbers up to their full authorized levels
Woodcock Stays At CDER: Drug Center’s Gain Is FDA Science Program’s Loss
Janet Woodcock's move to become director of the Center for Drug Evaluation and Research illustrates the operational challenges FDA faces: The agency remains deeply committed to its historic bargain with the drug industry to take user fees in order to improve application review, but it is finding it increasingly hard to meet deadlines or to perform any other outside projects